The booming uptake of anti-obesity drugs in India is further underscored by rising momentum of Eli Lilly's Mounjaro, which ...

I love how the GLP-1 medication subdues my appetite. It still seems miraculous to be able to say 'no' to cakes, desserts and ...

Mounjaro has released once-weekly injections that are helpful in managing type 2 diabetes along with showing remarkable results in sustainable weight loss. But how is this better than traditional ...

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli Lilly began marketing its rival product Mounjaro in the world's most populous ...

From today, it’s become legal for GPs to prescribe the Mounjaro jab to users, adding to the estimated 500,000 people who are already using it and Wegovy to lose weight.

And now, social media forums are booming with stories of users trying to get that last dose out, either by injecting it, or using syringes to extract the leftover liquid to inject later.

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Mounjaro is an antidiabetic drug which lowers blood sugar levels and slows down how quickly food is digested (Alamy/PA) It looks like the weight-loss injection craze isn’t going away any time soon.

Mounjaro is an antidiabetic drug which has boomed in popularity because of how it works as an appetite suppressant. It’s already the dominant weight loss drug on the market, which is delivered ...

As Mounjaro gets rolled out on the NHS legitimately, some other medications are also cropping up with far less reliable outcomes. One pharmacist explains how to tell the difference ...